Philip Douglas Ceriani, MD | |
38638 Stucker Mesa Rd, Hotchkiss, CO 81419-6214 | |
(970) 527-7064 | |
(970) 527-7064 |
Full Name | Philip Douglas Ceriani |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 38638 Stucker Mesa Rd, Hotchkiss, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679852933 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 17445 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Philip Douglas Ceriani, MD 38638 Stucker Mesa Rd, Hotchkiss, CO 81419-6214 Ph: (970) 527-7064 | Philip Douglas Ceriani, MD 38638 Stucker Mesa Rd, Hotchkiss, CO 81419-6214 Ph: (970) 527-7064 |
News Archive
SCIENTISTS at the University of Huddersfield are pioneering the use of a special gel that is ideal for administering medication to young children and others - including the elderly - who have difficulty swallowing pills and capsules. Unlike purely liquid medicines, the gel delays the release of the drug, so that it has maximum effect.
The number of Danes who contracted a salmonella infection reached a historic low level in 2013. More than half of those infected became ill during a trip abroad.
An epidemic of childhood obesity can have a devastating impact on a child's musculoskeletal system, the U.S. Bone and Joint Decade says. Extra weight stresses growing bones, causing pain and interfering with normal growth and development.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
Motivated by the need to achieve cost-effective and high-quality care, the European healthcare industry is increasingly turning to computerised physician order entry (CPOE) systems.
› Verified 6 days ago